4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
AVITA Medical, Inc. (RCEL) operates in the Medical Devices industry and is headquartered in Valencia, United States with about 226 employees. Its market capitalization is roughly $136 million. In the fiscal year ended 2025-12-31, RCEL reported $72M in revenue and ($49M) in net income.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Interactive charts & full statements → Open the RCEL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $72M | $64M | $50M | $34M |
| Gross Profit | $59M | $55M | $42M | $28M |
| Operating Income (EBIT) | ($42M) | ($57M) | ($43M) | ($28M) |
| Net Income | ($49M) | ($62M) | ($35M) | ($27M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $19M | $18M | $17M | $18M | $18M |
| Gross Profit | $16M | $14M | $14M | $15M | $16M |
| Operating Income (EBIT) | ($9M) | ($10M) | ($9M) | ($11M) | ($12M) |
| Net Income | ($11M) | ($12M) | ($13M) | ($10M) | ($14M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $56M | $80M | $112M | $98M |
| Total Liabilities | $73M | $75M | $63M | $14M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RCEL viewer.
About TickerBase · Data methodology & sources